Sign in

CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company

Silence Therapeutics plc

Sign in to watch
Tickers
SLN SLNCF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
operating
Phone
44-0-20-3457 6900
Business address
12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP

Securities

  • SLN American Depository Share Nasdaq
  • SLNCF Common stock OTC
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Insider Changes in Ownership
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. 8-K Event Executive or director change · Regulation FD disclosure
  7. 4 Insider Changes in Ownership
  8. 10-K/A Report 10-K/A
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. SCHEDULE 13D/A Stake Beneficial Ownership Report
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 10-K Report Annual Report

Page 5 of 14 · 278 filings